Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donor Atorvastatin for GVHD Prevention
NCT01525407Phase 2Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- May 2012
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of atorvastatin in graft-versus-host disease (GVHD), sponsored by Fred Hutchinson Cancer Center. Started May 2012; status: completed.
02
Drugs
atorvastatin
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT01525407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01525407.